欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/3112/006
药品名称Temozolomid Fresenius Kabi 250 mg Hartkapseln
活性成分
    • temozolomide 250.0 mg
剂型Capsule, hard
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 D-61352 Bad Homburg v.d.H.
参考成员国 - 产品名称Germany (DE)
Temozolomid Fresenius Kabi 250 mg Hartkapseln
互认成员国 - 产品名称
    • Croatia (HR)
      Temozolomid Fresenius Kabi 250 mg tvrde kapsule
    • Denmark (DK)
    • Belgium (BE)
      Temozolomide Fresenius Kabi 250 mg capsules, hard/gélules/Hartkapseln
    • Netherlands (NL)
    • Iceland (IS)
    • United Kingdom (GB)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Bulgaria (BG)
    • Cyprus (CY)
      TEMOZOLOMIDE FRESENIUS KABI 250mg HARD CAPS
    • Czechia (CZ)
      Temozolomide Fresenius Kabi 250 mg
    • Estonia (EE)
    • Hungary (HU)
      TEMOZOLOMID Fresenius Kabi 5-20-100-140-180-250 mg kemény kapszula
    • Lithuania (LT)
      Temozolomid Fresenius Kabi 250 mg kietosios kapsulės
    • Latvia (LV)
    • Malta (MT)
      Temozolomide Fresenius Kabi Capsules Hard 250mg
    • Poland (PL)
    • Romania (RO)
      Temozolamida Fresenius Kabi 250 mg capsule
    • Slovenia (SI)
    • Slovakia (SK)
许可日期2014/08/06
最近更新日期2016/02/24
药物ATC编码
    • L01AX03 temozolomide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase